Skip to content

Nationwide, the percentage of health care visits for flulike symptoms ticked up above the baseline at the start of November and has remained elevated ever since, according to the Centers for Disease Control and Prevention.

Nationwide, the percentage of health care visits for flulike symptoms ticked up above the baseline at the start of November and has remained elevated ever since, according to the Centers for Disease Control and Prevention.

Published on

Stanford Medicine researchers are designing vaccines that might protect people from not merely individual viral strains but broad ranges of them. The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.

Stanford Medicine researchers are designing vaccines that might protect people from not merely individual viral strains but broad ranges of them. The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.

Published on

Post-Nobel Prize announcement, we're spotlighting the science behind the mRNA-based COVID-19 vaccine and how it may impact medicine broadly.

Post-Nobel Prize announcement, we're spotlighting the science behind the mRNA-based COVID-19 vaccine and how it may impact medicine broadly.

Stanford Medicine infectious disease expert Anne Liu provides guidance on the RSV, flu and new COVID-19 vaccines this fall.

Stanford Medicine infectious disease expert Anne Liu provides guidance on the RSV, flu and new COVID-19 vaccines this fall.

Published on

Scientists explain a key difference between the spike-protein molecules generated by the SARS-CoV-2 mRNA vaccine and those the virus induces.

Scientists explain a key difference between the spike-protein molecules generated by the SARS-CoV-2 mRNA vaccine and those the virus induces.

Published on

Researchers at Stanford are devising new ways to deliver mRNA to the body to facilitate more potent and accurate treatments and vaccines.

Researchers at Stanford are devising new ways to deliver mRNA to the body to facilitate more potent and accurate treatments and vaccines.

Stanford pathologist speaks to the likelihood of undetectable COVID-19 and best practices for staying safe in the face of uncertainty.

Stanford pathologist speaks to the likelihood of undetectable COVID-19 and best practices for staying safe in the face of uncertainty.

By harnessing an antibody most overlooked, researchers devise a new possible way to stop viruses, even as they evolve.

By harnessing an antibody most overlooked, researchers devise a new possible way to stop viruses, even as they evolve.

Published on

Researchers are harnessing an imaging technique called cryogenic electron microscopy to design drugs and better understand disease.

Researchers are harnessing an imaging technique called cryogenic electron microscopy to design drugs and better understand disease.

Published on

Researchers at Stanford Medicine are working to develop antivirals to stop the current pandemic and prevent ones.

Researchers at Stanford Medicine are working to develop antivirals to stop the current pandemic and prevent ones.

Published on

Stanford Medicine researchers and others study a deadly virus -- the Nipah virus -- in a high-clearance safety laboratory.

Stanford Medicine researchers and others study a deadly virus -- the Nipah virus -- in a high-clearance safety laboratory.